| | Osteoarthritis |
| 316 | For patients who have failed an adequate trial of acetaminophen (e.g. acetaminophen 1g QID for several weeks) and have had: |
| | History of a documented, clinically significant ulcer or GI bleed; or
Failure or intolerance to at least three listed NSAIDS. |
| | NOTE: The maximum daily dose of celecoxib which will be reimbursed for the treatment of osteoarthritis is 200mg. |
| | LU Authorization Period: 1 year |
| | Rheumatoid arthritis |
| 317 | For patients who have had: |
| | History of a documented, clinically significant ulcer or GI bleed; or
Failure or intolerance to at least three listed NSAIDS. |
| | NOTE: The maximum daily dose of celecoxib which will be reimbursed for the treatment of rheumatoid arthritis is 400mg. |
| | LU Authorization Period: 1 year |
